Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the effect of the glucose insulin potassium (GIK) infusion associated with intensive insulin therapy compared to GIK alone and control group in patients presenting to the ED with acute coronary syndrome.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• All patients fulfilling ACS criteria with or without known diabetes.

Exclusion Criteria:

• Patients under 18 years old.

• Killip II class or SaO2 ≤ 90%.

• Blood creatinine ≥ 180 µmol/L

• Potassium serum ≥ 6.5 mmol/L.